Clinical Trial Update: A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2a study evaluated the safety, immunogenicity, and efficacy of the malaria vaccine FMP2.1/AS01B for Plasmodium falciparum malaria and has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• FMP2.1/AS01B

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Falciparum Malaria | Phase 1, Phase 2 | Status: COMPLETED